DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Sledge Jr GW, Toi M, Neven P. et al.
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2−
Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy.
J Clin Oncol 2017;
35: 2875-2884
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.